NeoGenomics, Inc. (NASDAQ: OTCBB: NGNM), a leading provider of cancer-focused genetic testing services, announced today that it has validated and launched the first molecular assay for clinical use in the United States that detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1).
Response Biomedical Corp. (TSX:RBM) (OTCBB:RPBIF) will release its second quarter financial results for the period ending June 30, 2012 after markets close on Tuesday, August 7, 2012.
MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that the Company has raised over $4.9 million through the exercise of Callable Warrants issued in conjunction with the October 2010 Private Placement.
MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") today called attention to the annual National Physicians Survey showing that fax remains the predominant form of communication for 63% of healthcare providers. MMRGlobal owns numerous worldwide patents encompassing hundreds of
CompuMed, Inc. (PINKSHEETS: CMPD) (www.compumed.net), a medical informatics and telemedicine services company, has secured a contract extension to provide its signature CardioGram™ electrocardiogram (ECG) remote interpretation system and over-read services for the Oklahoma Department of Corrections (OKDOC).
Cytomedix, Inc. (OTCBB: CMXI) (OTCQB: CMXI) (the "Company"), a regenerative therapies company commercializing and developing innovative platelet and adult stem cell technologies for wound and tissue repair, today announced that the Centers for Medicare & Medicaid Services ("CMS") has issued a final National Coverage Determination ("NCD") for autologous blood-derived products for chronic non-healing wounds.
CytoSorbents Corporation (OTCBB: CTSO), a pioneer in the use of blood purification to treat life-threatening illnesses such as sepsis, trauma, burn injury, lung injury and pancreatitis, announced that the Defense Advanced Research Projects Agency, or DARPA, has awarded the Company a technology development contract worth up to $3.8 million as part of its Dialysis-Like Therapeutics (DLT) program to treat sepsis, pending satisfactory achievement of key milestones
AeroGrow International, Inc. (PINKSHEETS: AERO) ("AeroGrow" or the "Company"), makers of the AeroGarden® line of indoor gardening products, will host a conference call on Friday, August 10, 2012, to review operational results for the quarter ended June 30, 2012.
BioLargo, Inc. (OTCBB: BLGO) announced today that former Smith & Nephew Vice President of Innovation (and Vice President at Smith & Nephew Wound Management) Tanya Rhodes has joined the BioLargo management team as a senior strategy advisor.
Bion Environmental Technologies, Inc. (OTC BB/QB: BNET) announced today that it was notified that its Canadian patent application 2503166 entitled "Low Oxygen Biologically Mediated Nutrient Removal" has been approved.
News 
Market Data 
Discover 
